Despite their narrow therapeutic index, most antineoplastic drugs are widely used in combination therapies. However, other drug interactions may either enhance or diminish the antitumor effects of antineoplastic drugs and enhance their side effects. Concurrent use of an antineoplastic agent and the inhibitors of Cytochrome P450 (CYP) isoenzymes, including CYP3A4, CYP2B6, and CYP2D6, and other hepatic isoenzymes may even potentially delay the elimination of an antineoplastic agent and enhance its activity or toxicity. Therefore, it is crucial to exercise caution while prescribing other therapeutic agents to patients undergoing active anticancer therapy.
Solve this question to test your knowledge of the side effects of antineoplastic drugs. Which of the following is NOT a common adverse reaction of antineoplastic drugs? Euphoria Stomatitis Anorexia Alopecia ##Disclaimer## The content…
